...Changing The World

Michelson Prizes for Human Immunology and Vaccine Research [HVP].

Project Description

Michelson Prizes for Human Immunology and Vaccine Research — $150K Prizes for Young Investigators awarded via the Human Vaccines Project

Grantee Year Issue Initiative
Michelson Prizes | Human Vaccines Project [Logo] 2017 A new approach to vaccination is needed which will identify and understand common elements of the human immune system across populations and harness the collective knowledge of scientists across the world in order to prevent and control of infectious diseases and cancer. Michelson Prizes for Human Immunology and Vaccine Research
Grantee Michelson Prizes | Human Vaccines Project [Logo]
Year Issue Initiative
2017 A new approach to vaccination is needed which will identify and understand common elements of the human immune system across populations and harness the collective knowledge of scientists across the world in order to prevent and control of infectious diseases and cancer. Michelson Prizes for Human Immunology and Vaccine Research
Grantee Michelson Prizes | Human Vaccines Project [Logo]
Year 2017
Issue A new approach to vaccination is needed which will identify and understand common elements of the human immune system across populations and harness the collective knowledge of scientists across the world in order to prevent and control of infectious diseases and cancer.
Initiative Michelson Prizes for Human Immunology and Vaccine Research
Grantee Michelson Prizes | Human Vaccines Project [Logo]
Year 2017
Issue A new approach to vaccination is needed which will identify and understand common elements of the human immune system across populations and harness the collective knowledge of scientists across the world in order to prevent and control of infectious diseases and cancer.
Initiative Michelson Prizes for Human Immunology and Vaccine Research

A new approach to vaccination is needed which will identify and understand common elements of the human immune system across populations and harness the collective knowledge of scientists across the world in order to prevent and control of infectious diseases and cancer. The Michelson Medical Research Foundation [MMRF] and its founder, Dr. Gary K. Michelson, have partnered with the Human Vaccines Project in order to achieve this. Together, they have established the The Michelson Prizes for Human Immunology and Vaccine Research, which will help facilitate the development of future vaccines and therapies.

Michelson Prizes for Human Immunology and Vaccine Research

December 13, 2017 | Los Angeles and New York

The Michelson Medical Research Foundation [MMRF] has funded a $20 million initiative with the Human Vaccines Project to support young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Michelson Prizes | Gary Karlin Michelson, M.D., founder of the Michelson Medical Research Foundation.

Gary Karlin Michelson, M.D., founder of the Michelson Medical Research Foundation: The prizes give young scientists the freedom to think outside-of-the box and explore disruptive technologies… Our collaboration with the Human Vaccines Project in establishing the Michelson Prizes will help unravel the complexity of the human immune system to accelerate development of vaccines and therapies for some of the world’s most threatening diseases.

A rigorous and competitive search will be undertaken, globally, to identify the most innovative projects by young scientists across a broad spectrum of scientific fields. Proposals will be reviewed and winners selected by a distinguished committee of internationally-recognized, independent scientists.

Wayne Koff, PhD, President and CEO of the Human Vaccines Project (Credit: MIT Sloan School of Management Kendall Square, Cambridge MA)

Wayne Koff, PhD, President and CEO of the Human Vaccines Project

Most of the discoveries in science have been made by individuals in the early stages of the careers in science… one of the issues that the young investigators are facing now is that it’s very difficult to get their initial grant…[and] it’s very difficult to get support for ideas that are outside of the box, where there isn’t a lot of preliminary data, where there’s a potential to really have a disruptive impact.

When Gary Michelson and I had a discussion about this, we each agreed that if we could create a mechanism to identify individuals who are really thinking outside the box, who are not looking to do incremental science but are looking to do transformative science – would we be able to identify the needle in the haystack.

The Prize Details

  • Pre-application Due Date: February 12, 2018 (Pre-Application Time Period has now closed.)
  • Notification to Submit Full Application: March 5, 2018 (Application Time Period has now closed.)
  • Two investigators under the age of 35 will each be awarded a $150,000 prize
  • The two prizes will be awarded on June, 27 2018 as part of a conference on the Future of Vaccine Development hosted at the Michelson Center for Convergent Bioscience at the University of Southern California
  • Awardees will be expected to give an oral presentation of their awarded program at this conference

Eligibility and Application Criteria

  • Applicants must be under the age of 35 (born on or after February 12, 1983) and affiliated with a research organization in the academic, nonprofit, industry or public sector
  • To be considered, applicants need to show how he or she is going beyond conventional approaches in their field and clearly articulate how the contribution will make a lasting impact on human immunology and vaccine research
  • While the Michelson Prizes are focused on research outcomes in the fields of human immunology and vaccinology, early career scientists across a wide array of disciplines, including clinical research, biomedicine, bioengineering, artificial intelligence/machine learning, and nanotechnology, are encouraged to apply
  • International applicants are encouraged
  • Applicants may submit only one application per year
  • Prizes will be awarded to individuals, not institutions

How To Apply

Pre-application time period has now closed.
Notification to Submit Full Application: March 5, 2018

About The Human Vaccines Project

The Human Vaccines Project is a nonprofit public-private partnership with a mission to decode the human immune system to accelerate the development of vaccines and immunotherapies against major infectious diseases and cancers. The Project brings together leading academic research centers, industrial partners, nonprofits and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.

Support and funding for the Project includes the Robert Wood Johnson Foundation, John D. and Catherine T. MacArthur Foundation, the Michelson Medical Research Foundation, GSK, MedImmune, Illumina, Sanofi Pasteur, Johnson and Johnson/Janssen, Pfizer, Moderna, Boehringer Ingelheim, Aeras, Vanderbilt University Medical Center, University of California San Diego, The Scripps Research Institute, J. Craig Venter Institute and La Jolla Institute for Allergy and Immunology.

Michelson Prizes: Young Scientists (Credit: Pressmaster/Envato Elements)

While the Michelson Prizes are focused on research outcomes in the fields of human immunology and vaccinology, early career scientists across a wide array of disciplines, including clinical research, biomedicine, bioengineering, artificial intelligence/machine learning, and nanotechnology, are encouraged to apply.

Michelson Prizes | Human Vaccines Project - Wayne Koff, PhD, President and CEO of the Human Vaccines Project

Wayne Koff, PhD, President and CEO of the Human Vaccines Project: “The Michelson Prizes support the missions of both MMRF and the Human Vaccines Project, with the ultimate goal of broadening our understanding of the human immune system to give the scientific community new tools to help prevent and control disease, potentially saving millions of lives across the world… We are honored to be collaborating with the Michelson Medical Research Foundation to implement the visionary commitment of Gary and Alya Michelson of supporting the next generation of scientific leaders on the frontiers of human immunology and vaccine research.”

Image Credit

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Gary Karlin Michelson, M.D. and Alya Michelson from the Michelson Medical Research Foundation are proud sponsors of the Michelson Prizes for Human Immunology and Vaccine Research, in partnership with the Human Vaccines Project, which supports young investigators applying innovative research concepts and disruptive technologies to defeat major global diseases by significantly advancing the development of future vaccines and therapies.

Back to Top